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ABSTRACT 
Twenty-seven trials assessing behavioural treatments for premature ejaculation were 
reviewed. Their effects were estimated intermediate to large. Most of them used 
techniques of pauses (i.e., “stop-start”). Some added penile compression techniques 
(i.e. “squeeze”) and some added the support of a vibratory device, but these 
adjunctions did not appear to provide further significant benefits. Other techniques 
aiming to regulate motor, respiratory and attentional components of sexual arousal 
(i.e. “regulating” or “sexual-functional” approach) also seemed efficient. On the other 
hand, exercises specifically designed to rehabilitate the pelvic floor did not appear 
clearly effective. The therapeutic processes were generally regarded as related to 
habituation-desensitization mechanisms and/or learning to self-regulate one’s 
excitement. It also seemed important to accompany the patient in order to ensure the 
proper use of the techniques and to address possible cognitive, behavioural and 
relational issues related to the sexual complaint. When access to sex therapy is 
difficult, it is still possible to recommend a self-treatment (i.e., “bibliotherapy”) as a 
first-line approach. 
INTRODUCTION 
Premature Ejaculation (PE) is considered a difficulty that meets three criteria: it is an 
ejaculation [1] that occurs quickly, [2] that the man feels he cannot control and [3] that 
causes a feeling of distress [4-6]. This general description covers a diversity of clinical 
situations that can be characterized in at least two ways: the difficulty can be either 
lifelong or acquired, depending on whether it appeared at the beginning of the 
person's sexually active life or after a period of deemed normal functioning [4,6-8]. 
PE can then be described as either generalized or situational (or variable), depending 
on whether it occurs in all sexual situations, including masturbation, or only under 
certain conditions [4,6,8]. Finally, a distinction can be made according to the average 
penetration time to compare primary and acquired PEs that occurs within a maximum 
of 1 to 3 minutes of penetration with so-called subjective PEs, in which the penetration 
times are most often longer than 4 minutes and are therefore quite similar to those 
found in the general population [7,8-10]. The subdivision of the PE into several 
categories is based on the idea that the different subtypes of the disorder probably 
obey different causes and that they would therefore require differentiated 
management strategies. Yet, as Puppo and Puppo [11] point out, the question of the 
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causes of PE remains rather unclear. Research highlights 
multiple risk factors, such as genetic factors [12,13], hormonal 
factors, as well as cognitive [14], emotional [15,16] or 
neurophysiological [17,18] factors. However, at the end, very 
little is known about their true causal impact, relative weight 
and possible interactions. Whatever its specific form, PE seems 
to result primarily from a complex entanglement of biological 
and psychosocial processes for which it would be bold to 
establish the exact formula [19]. Given the current state of 
knowledge, it seems futile to establish a correspondence 
between the type of PE and the type of treatment indicated, 
i.e. behavioural or pharmacological. From a heuristic clinical 
point of view, PE can hardly be characterized in any way other 
than as a biological condition that can be modulated either 
chemically or behaviourally, with the choice of strategy 
becoming mainly a matter of preference [20,21].  
The efficacy of serotonin reuptake inhibitor molecules is clearly 
established. The characteristics, effects and limitations of 
available products are well documented. This situation provides 
clinicians with convenient guidelines [22,23]. Things are far 
from being so clear about sex therapies. There are many 
studies in this area, but they have various methodological 
qualities [24,25]. The series to which they relate are often 
small. Their results sometimes appear contradictory and the 
description of the treatments they propose sometimes remains 
imprecise. According to an estimate by the International Society 
for Sexual Medicine (SIMS), the effectiveness of behavioural 
treatments did not exceed Level 2b in 2010 [9]. The terms 
"psychological", "sexological" or "behavioural", by which they 
are summarized, also refer to multimodal treatments composed 
of a variety of techniques whose combination can vary greatly 
from one model to another [3]. This situation leaves the non-
specialized clinician with an impression of complexity, even 
blurred. However, there is a significant amount of cumulative 
empirical data and a decline of several decades that allows 
for some clarification.  
The purpose of this article is to identify published papers in the 
field and to draw general lessons from them. 
METHODOLOGY 
Since the inaugural publications of Semans [26] and Masters 
and Johnson [27], several clinical trials have been conducted on 
the behavioural approach to PE. A census was conducted in 
April 2019, based on traditional databases (PubMed, Scopus, 
Psyc INFO). Work not listed in these databases but cited by 
relevant sources has also been included, provided that reports 
have been accessible at least in summary form. This is the case 
for some of the oldest works as well as those of De Sutter et 
al., [28] Shao & Li [29] and Yuan et al., [30]. The census 
targeted all studies that reported pre- vs. post-treatment 
measures. Twenty-seven trials were identified. The publications 
run from 1956 to 2019, and include one article in French [28] 
and four in Chinese [29-32]. As the latter language is unknown 
to the authors of this article, only information from their English 
abstracts [31,32] or a detailed analysis by Cooper et al., [24] 
[29,30] was taken into consideration. 
RESULTS 
The list of trials of behavioural treatments for PE is shown in 
(Table 1). 
In 1956, Semans was the first to develop and test a 
behavioural technique specifically applicable to PE, a 
technique based on "pauses". This pause technique, usually 
called "stop-start", is still one of the cornerstones of sex 
therapy today. The patient is asked to masturbate (or be 
masturbated) until he feels an excitation close to ejaculation. 
The stimulation is then stopped ("stop") until the excitation has 
significantly decreased, then it is restarted ("start") and 
stopped again before ejaculation occurs. The operation is 
repeated several times before allowing the man to ejaculate. 
The exercise is repeated regularly until the patient is able to 
postpone his ejaculation at will. The stop-start is then applied in 
a coital situation until the man also achieves satisfactory 
control. The pause technique was used in almost all the trials 
reviewed, with uncertainty for those of De Amicis et al., [33], 
Tang et al., [32], Li et al., [31], Yuan et al., [30] Mohammadi et 
al., [34] and Pavone et al., [35], for which we did not find 
detailed information on the techniques used. In 1970, Masters 
and Johnson revisited the Semans technique by enhancing it, 
during the stopping phases, with pinches applied either to the 
root of the penis or under the crown of the glans. This 
procedure, called "squeeze technique", has certainly been 
adopted by Lowe & Mikulas [36], Golden et al. [37], Zeiss 
[38], Kolodny, Masters& Johnson [39], Trudel & Proulx [40], 
Abdel-Hamid, El Nagger & El Gilany [1], Cormio et al. [41], 
Mantovani [42] and in the "standard" treatment in the essays 
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by Jern [43] Cui et al. [44] and Rodriguez, Marzo & Piqueras 
[45], the pause exercises were assisted by a vibratory device. 
Mantovani [42] and Rodriguez, Marzo & Piqueras [45] have 
also associated pelvic muscle rehabilitation exercises. In 
addition to, or even in place of, pause techniques, some authors 
have proposed postural, respiratory and muscle relaxation 
techniques to regulate the release of excitement [28,46,47].  
Pause techniques and their variants were usually integrated 
into a broader therapeutic format that also includes psycho-
education sessions, sensory reconditioning exercises such as the 
"sensate focus" [27] and attention to a series of individual or 
relational difficulties that may interfere with the problem. 
Sexual scripts may be inadequate, communication deficient, 
emotions at the surface of the skin, etc., in short, beyond the 
simple question of ejaculation delays, various elements can 
work to tarnish sexual satisfaction, it is important to take this 
into account. In addition to behavioural techniques specifically 
aimed at restoring male control over ejaculatory latency, it is 
therefore important to address a number of related difficulties, 
we would say "to clean up the context". However, the methods 
used for this purpose are not specific to PE problems, they 
apply to a multitude of sexual difficulties and thus characterize 
the sex therapy approach as a whole. Masters & Johnson [27] 
have focused on these non-specific components of treatment, it 
can be assumed that the same is true for authors who more or 
less explicitly claimed their therapeutic (De Carufel & Trudel 
[2006] in their "standard" treatment) [33,36-38,40,48,49] but 
it is difficult to determine to what extent. Some authors also 
stated that they have worked in a broader context but without 
referring specifically to the Masters & Johnson format (De 
Carufel & Trudel [2006]) [28,35,41,46,50,51] in their 
"functional-sexological" treatment. Others did not say anything 
about it or, in any case, we had no information on it [30-
32,42-45]. 
Some authors expressed their results in terms of "cure" rates, 
i.e. in a categorical mode, where the number of beneficiaries 
improved by the method was specified, and the criteria for 
improvement might vary from one study to another. Other 
authors presented their results in a rather parametric way: the 
penetration times before vs. after treatment were detailed as 
well as the participants' progress on self-assessment scales 
relating to their sense of control and distress. One of the 
advantages of such a methodology is that it can be used for 
standardized measures of effect sizes, provided, of course, 
that the ad hoc indicators were reported.  
Table 2 reports effect sizes (Cohen's d) related to the extension 
of penetration times after behavioural treatment used as 
monotherapy. Effect sizes were calculated based on published 
figures from trials with at least one arm using a sex therapy 
approach as the sole treatment. They concerned so-called 
"IELT" measurements (Intravaginal Ejaculatory Latency Time) as 
objectively measured using a stopwatch or as reported by the 
participants (subjective IELT), measurements that were 
expressed in minutes or seconds, except in Kempeneers et al. 
[46,47] where they were expressed in terms of slices (1. ante 
portas, 2. < 30 sec, 3. between 30 sec and 1 min, 4. between 
1 and 2 min, etc.) The effects of the treatments are also 
presented as multipliers of the penetration times measured in 
the baseline as well as in average penetration times (minutes) 
after treatment. Table 2 also provides details on treatment 
and follow-up times.  
In terms recommended by Cohen (1988), the effects of 
behavioural treatments range from “small” (d < .20) in one 
occurrence [34] to "intermediate" (d between .40 and .80) in 
four [45-47] and "large" (d > .80) or even "very large" (d > 
1.30) in the other nineteen occurrences. This generally argues in 
favour of recognizing the effectiveness of the behavioural 
approach while drawing attention to variations that may shed 
light on certain conditions of relative effectiveness of the 
methods. These variations are one of the subjects of the 
following discussion. 
(Table 3) is constructed according to the same principle as 
(Table 2) but it concerns trials comparing behavioural and 
pharmacological approaches alone or in combination.  
The experience of PE is not reduced to short periods of 
penetration, it also implies a feeling of lack of control and 
suffering. Composite scales have therefore been used by 
several authors to report clinical pictures in their multiple 
dimensions. These include the PEDT (Premature Ejaculation 
Diagnostic Tool) used by Cormio et al. [41] and Pavone et al. 
[35], the GRISS-PE (Golombok Rust Inventory of Sexual 
Satisfaction for PE) used by Van Lankveld et al. [51], the AIPE 
(Arabic Index of Premature Ejaculation) used by Mohammadi 
et al. [34], CHEES (Checklist for Early Ejaculation Symptoms) 
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used by Jern (2013), CIPE (Chinese Index of Premature Ejaculation) used by Cui et al. [44], and PEP (Premature Ejaculation Profile) 
used by Kempeneers et al. [47]. In the terms proposed by Cohen (1988), effect sizes range from small in one occurrence [34] to 
intermediate in three occurrences [51], and pharmacological treatment alone by Pavone et al., [35] and large or very large in all 
others. However, the heterogeneity of the measurements makes it difficult to compare between trials. Let us simply observe that 




on PE with 
IELT < 2 min 








Semans [26] 9 no sex therapy none improvements in 8 of the 9 subjects treated Categorical 
Masters & 
Johnson [27] 
186 no sex therapy none improvements in 98% of subjects Categorical 
Lowe &Mikulas 
[36] 
10 no bibliotherapy + phone accompaniment waiting list improvements in the 10 subjects treated Categorical 
Golden et al., [37] 15 no group sex therapy / couple sex therapy none 
equivalent improvements with both 
therapeutic formats 
Parametric 
Zeiss [38] 20 no 
sex therapy (n = 6) / bibliotherapy (n = 6) / 
bibliotherapy + minimal accompaniment (n 
= 6) 
none 
improvements using standard formats and 
accompanied bibliotherapy, not in the case 
of bibliotherapy alone 
Categorical 
Kolodny, Masters 
& Johnson [39] 
246 no sex therapy none improvements in 95% of subjects Categorical 
De Amicis et al., 
[33] 
20 no sex therapy none 
significant improvements after treatment, 
failure to maintain achievements after three 
years with continued sexual satisfaction 
Categorical 
Hawton et al., 
[48] 
8 no sex therapy none 
significant improvements after treatment in 
6 subjects. Retention of achievements in 





sex therapy / bibliotherapy / bibliotherapy + 
minimal accompaniment 
waiting list 
improvements using all three therapeutic 






sex therapy (n = 6) / sildenafil (n = 6) / 
clomipramine (n = 7) / sertaline (n = 6) / 
paroxetine (n = 6) 
none 
superiority of sildenafil over other 
treatments, superiority of paroxetine over 
sex therapy 
Parametric 
De Sutter et al., 
[28] 
64 no biblioherapy (n = 64) 
waiting list (n = 
32) 
improvements in 55% to 65% of subjects at 
two months 
Categorical 
Tang et al., [32] 60 unknown 
sex therapy (n = 30) / sex therapy + 
sildenalfil (n = 30) 




32 no sex therapy (n = 16) / fluoxetine (n = 16) none 
equivalent improvements (50% - 62.5%) 





"standard" sex therapy (n = 18) / 
"functional-sexological" therapy (n = 18) 
waiting list (n = 
18) 
equivalent improvements with both active 
treatments 
Parametric 
Li et al., [31] 90 unknown 
clomipramine / clomipramine (n = 45) + 
sex therapy (n = 45) 
none superior efficiency of combined treatment Parametric 
Shao & Li.[29] 120 unknown 
sex therapy (n = 40) / paroxetine (n = 40) / 
paroxetine + sex therapy (n = 40) 
none 
sex therapy + paroxetine > paroxetine alone 
> sex therapy alone 
Parametric 
Yuan et al., [30] 96 unknown 
sex therapy (n = 32) / citalopram (n = 32) / 
citalopram + sex therapy (n = 32) 
none 
sex therapy + citalopram > citalopram alone 
> sex therapy alone 
Parametric 
Van Lankveld et 
al., [51]  
36 no internet-based sex therapy 
waiting list (n = 
16) 
equivalent improvements in active treatment 





partly (n = 55 
with IELT < 1 
min) 
bibliotherapy (n = 120, or n = 55 in case of 
LLPE with IELT < 1 min) 
waiting list (n = 
66, or n = 35) 
improvements to 6 and 12-month maturities Parametric 
Jern [43] 11 no sex therapy with vibratory device 
waiting list (n = 
5) 
improvements at 6-month maturity Parametric 
Mohammadi et 
al., [34] 
12 no sex therapy none improvements after treatment Parametric 
Cormio et al., [41] 50 yes 
dapoxetine (n = 25) / dapoxetine + sex 
therapy (n = 25) 
none sex therapy + dapoxetine>dapoxetine alone Parametric 
Pavone et al., 
[35] 
157 yes 
sex therapy (n = 59) / dapoxetine (n = 62) / 
group sex therapy + dapoxetine (n = 36) 
none 
sex therapy + dapoxetine = sex therapy 
alone >dapoxetine alone 
Parametric 
Mantovani [42] 18 yes 
sex therapy / dapoxetine / dapoxetine + 
sex therapy 
none 
superiority of combined treatment at 6-
month after treatment 
Categorical 
Table 1: Synopsis of sex therapy trials for PE with post-treatment assessments. 
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Cui et al., [44] 86 yes 
sex therapy with vibratory device (n = 6) / 
traditional herbal medicine spray (n = 6) / 
sex therapy with vibratory device + herbal 
medicine spray (n = 6) 
none 





71 partly (n = 48) 
bibliotherapy (n = 36) / bibliotherapy + 
minimal accompaniment (n = 34) 
none similar improvements in both groups Parametric 
Rodriguez, Marzo 
& Piqueras. [45] 
35 yes 
sex therapy (n = 18) / sex therapy + 
vibratory device (n = 18) 
none 
sex therapy + vibratory device > sex 
therapy alone 
Parametric 
PE: Premature Ejaculation; IELT: Intravaginal Ejaculatory Latency Time; N: Number Of Subjects Treated; LLPE: Lifelong Premature 
Ejaculation. 
* Technical specifications not available. 
 
 
Trials N Measures Specifications d 
Confidence 






Golden et al., [37] 
10 IELT 
Group treatment at 2-month follow-
up 
2.26 0.67 - 3.84 5.11 14.05 
5 IELT 
Couple treatment at 2-month follow-
up 
1.17 - 0.73 - 3.07 5.08 7.31 
Trudel & Proulx. [40] 
na IELT 12- week standard sex therapy 4.22 na 6.32 10.78 
na IELT Bibliotherapy 2.61 na 5.78 11.05 
na IELT Bibliotherapy + phone contact 3.46 na 6.99 9.23 
Tang et al., [32] 30 IELT 
Behaviour therapy at post-
treatment 
2.50 1.55 - 3.46 2.28 1.82 
De Carufel & Trudel (2006) 
18 IELT 12-week standard sex therapy 2.55 1.31 - 3.79 8.31 7.87 
18 IELT 
12-week functional- sexological 
treatment 
2.65 1.39 - 3.92 8.64 8.18 
18 IELT 
Standard treatment at 3-month 
follow-up 
1.88 0.77 - 2.98 11.01 7.80 
18 IELT 
Functional- sexological treatment at 
3-month follow-up 








12-week functional- sexological 
treatment 




Standard treatment at 3-month 
follow-up 




Functional-sexological treatment at 
3-month follow-up 
2.76 1.47 - 4.05 2.86 4.14 








Bibliotherapy at delivery + 6 month 
in the subsample of men with LLPE 
reporting IELT < 1min 








Bibliotherapy at delivery + 12 month 
in the subsample of men with LLPE 
reporting IELT < 1 min 
0.94 0.25 - 1.63 na na 
Jern. [43] 11 IELT 
6-week behavioural treatment at 6-
month follow-up 
1.67 0.30 - 3.04 2.30 3.37 





0.12 - 1.02 - 1.25 1.36 3.16 
Pavone et al., [35] 
93 (pretest) / 59 
(post test) 
IELT 16-week group therapy 12.39* 10.96 - 13.82 8.80 6.87 
Cui et al., [44] 28 IELT 6-week behavior therapy 2.21 1.27 - 3.15 2.71 3.14 








Bibliotherapy at delivery + 6 month 
in the subsample of men reporting 
IELT < 2 min 
0.91 0.31 - 1.5 na na 
Rodriguez, Marzo & Piqueras 
[45] 
17 IELT 7-week behavioural treatment 0.46 - 0.50 - 1.42 1.33 1.45 
18 IELT 
7-week behavioural treatment with 
vibratory device 
1.22 0.21 - 2.22 2.37 2.78 
IELT: Intravaginal Ejaculatory Latency Time; LLPE: Lifelong Premature Ejaculation; N: Number of Subjects Assessed; d: Cohen's d; na: 
Not Available 
*Calculation adjusted to groups with different sample sizes. 
Table 2: Results on IELTs: effect sizes, growth and IELTs at post test. 
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IELT: Intravaginal Ejaculatory Latency Time; LLPE: Lifelong Premature Ejaculation; N: Number of Subjects Assessed; d: Cohen's d; na: 
Not Available 
* Calculation adjusted to groups with different sample sizes. 
 
DISCUSSION 
6.1. Evolution over five decades 
A first look at Table 1 leads to a global distinction between 
two periods. The first extends from the 1970s to the 1980s, 
and is characterized by studies involving only one arm and/or 
small sample size, with the notable exception of the trials 
conducted by Masters and his associates [27,39]. The results 
are mainly expressed in a categorical way, in terms of the 
proportion of improved beneficiaries. The other major period 
begins in the 2000s, when trials generally involve several arms, 
seeking to establish the effectiveness of behavioural methods 
by comparing them to the absence of treatment and/or other 
types of treatment, or by comparing them with each other. The 
sample size tends to increase here and the results are 
expressed more in a parametric mode, in terms of progress on 
various measures, the most important of which are penetration 
times. The tests also focus more on severe PEs with penetration  
 
 
times of less than one to two minutes. These two periods, which 
are quite different in terms of methodology, are separated 
from a period of more than ten years during which nothing new 
or virtually nothing has been published on sex therapy. This 
period seems to correspond to a phase of pharmacological 
development that, it seems, saw researchers turn away from 
behavioural methods and question the contribution of drugs, 
particularly serotonin reuptake inhibitors that were then 
appearing on the market. 
6.2. Years 1970s and 1980s 
The results obtained by Masters and his associates using their 
original approach on no fewer than 432 cumulative 
beneficiaries were spectacular: success rates exceeded 95%, 
success being understood as the possibility for the man to 
delay ejaculation until his partner's orgasm, in at least 50% of 
the reports [27,39]. Following the impetus provided by Masters 
and Johnson, other clinicians have published encouraging results 
Trials N Specifications d 




Mean IELT at 
posttest 
 
Tang et al., [32] 
30 Behaviour therapy at post-treatment 2.50 1.55 - 3.46 2.28 1.82 
30 Behaviour therapy + sildenafil at post-treatment 6.83 4.96 - 8.71 4.97 3.63 
Li et al., [31] 
45 Clorpromazine 10.01 7.86 - 12.15 6.70 4.76 
45 Clorpromazine + 6- week behaviour therapy 11.43 9.00 - 13.87 8.50 5.87 
Yuan et al., [30] 
32 Behaviour therapy after 6-week treatment na na na 2.21 
32 Citalopram na na na 5.76 
32 Behaviour therapy + citalopram na na na 6.22 
Cormio et al., 
[41] 
25 Dapoxetine at 24- week follow-up 2.11 1.13 - 3.09 1.88 2.67 
25 Dapoxetine + behavioural treatment at 24-week Follow-up 2.93 1.80 - 4.05 4.03 2.18 
Pavone et al., 
[35] 
62 Dapoxetineat 16- week post test 6.63* 5.82 - 7.43 4.57 3.86 
59 Group therapy at 16- week post test 12.39* 10.96 - 13.82 8.80 6.87 
36 Dapoxetine + group therapy at 16-week post test 12.59* 11.00 - 14.17 8.92 7.19 
Cui et al., [44] 
29 Traditional herbal medicine spray after 6-week treatment 1.80 0.94 - 2.66 2.60 2.99 
28 Behaviour therapy 2.21 1.27 - 3.15 2.71 3.14 
29 
Traditional herbal medicine spray + behaviour therapy after 6-
week treatment 
3.42 2.27 - 5.56 3.86 4,36 
Table 2: Results on IELTs: effect sizes, growth and IELTs at post test. 
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with similar therapeutic procedures focusing on break 
techniques: De Amicis et al. [33], Golden et al. [37], Hawton et 
al. [38], Trudel & Proulx [40] and Zeiss [38]; Kaplan [52], who 
was the apologist for the method but never published the 
details of her results, should also be mentioned. However, the 
documented trials involved small samples whose teachings were 
difficult to generalize and, with the exception of Trudel and 
Proulx [40], none included a control group, nor did the studies 
of Masters and Johnson. Most also produced less dramatic 
results than those published by Masters and Johnson and, even 
more annoying, De Amicis et al. [33] and Hawton et al. [48] 
observed relapse problems after three years. In total, in a 
1992 review, Saint Lawrence and Madakasira placed the 
average level of effectiveness of these methods between 43% 
and 65%, with values of more than 90% remaining exceptions 
[53]. In short, if the Masters and Johnson approach could claim 
a certain effectiveness, it was still necessary to question the 
extent of its effectiveness and its active ingredients. The 
question arose of possible recruitment bias: it could not be 
excluded, for example, that the excellent results reported by 
Masters and his associates were the result of a selection of 
exceptionally motivated subjects [54]; some also suggested 
that severe primary PEs characterized by penetration times of 
less than one or two minutes should be particularly under-
represented in these series, leaving the effectiveness of 
behavioural methods in these cases in doubt. The question still 
arose as to the efficiency itself of the break technique. 
Theoretically, this technique was supposed to cause the 
extinction of an ejaculatory response conditioned on speed, at 
least that is what Semans (1956) and Masters & Johnson 
[26,27] thought. Kaplan [52] argued that the pause allowed a 
better recognition of the sensations that herald orgasm, this 
competence being supposed to be lacking in PE subjects. 
However, research has never been able to confirm either the 
hypothesis of conditioning contingencies specific to men with PE 
or that of a deficient perception of their level of excitement 
[55,56]. If the method worked, it was probably not for the 
reasons initially imagined. This was the general state of play at 
the end of the first period. And it is conceivable that, in 
addition to the enthusiasm for new drug products, the 
associated feeling of methodological dissatisfaction may have 
helped to explain the apparent disaffection with the 
behavioural approach at the turn of the millennium. 
6.3. Years 2000 and 2010 
The 2000s saw a renewed interest in behavioural methods. 
Since pharmacological methods have also revealed their 
limitations [57,58], one of the central questions was the 
provision of treatment combining drug and sex therapy, the 
idea being, as Althof [2] put it, to offer beneficiaries, "the best 
of both worlds". Behavioural intervention also tended to 
theorize differently. Faced with the obvious absence of causes 
in the aetiological sense of the term [11,18], clinicians have 
gradually come to see PE as a variation of normality rather 
than a "disorder" of it. The focus shifted from the ejaculatory 
reflex itself, which obviously had no singularity, to the 
excitation process. Nourished by the contributions of research in 
the field of emotions [59,60], sex therapists now tended to 
conceive of the state of excitement as a complex process that, 
like any emotion, results from multiple reactions - physiological, 
cognitive, attentional, postural and motor - whose mutual 
reinforcement automatically leads to an exacerbation, which 
culminates and closes in orgasm [54,61,62]. The therapeutic 
intention was no longer so much an improbable re-education of 
the ejaculatory reflex, but rather aimed more at helping men 
to become aware of and modulate the discrete reactions that 
contribute to the exacerbation of their excitation. In 
neuroanatomical terms, this meant relying on the deliberate 
action of the prefrontal cortex to feedback control the muscular 
expression, including motor, respiratory and attentional 
components of a largely precognitive emotional reaction, i.e. 
excitation, triggered automatically by the limbal system. A 
subtle change in therapeutic attitudes was taking place: the 
classical technique of pauses was now conceived as a way of 
extending the total duration of the excitation experience by 
interrupting it regularly. Man thus more exposed to his 
sensations would be invited to pay attention to them, he would 
gradually get used to them and desensitize himself. If 
necessary, habituation-desensitization mechanisms could be 
facilitated by increasing the sensations of excitement using a 
vibratory device, as is the case with Cui et al. [44], Jern [43] 
and Rodriguez, Marzo & Piqueras [45]. It would also become a 
question of recommending the use of body postures and 
opposing movements to those automatically implemented in 
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excitation, in order to deliberately regulate its course; pauses 
therefore became a means of slowing down the excitation 
process in the same way as, for example, a slowing of 
copulatory movements, a modulation of breathing, muscular 
relaxation and a diffusion of attention over the whole body. 
De Carufel & Trudel (2006), De Sutter et al. [28] and 
Kempeneers et al. [46] place particular emphasis on these 
techniques, which are sometimes described as "regulatory" and 
sometimes "functional-sexological". 
6.4. Active Treatments vs. Waiting Lists 
The authors who used a control procedure almost all report 
significant differences in favour of active treatment. One 
exception is Van Lankveld et al. [51], who reported similar 
improvements in their experimental and control groups. It is 
important to note that while these authors did not find any 
group effect, they did observe a time effect that resulted in 
significant improvements in the GRISS-PE scale for both control 
and experimental group subjects at the end of the procedure. 
The effect sizes (d) are respectively 0.68 (Confidence intervals 
[CI] at 95%: -0.33 - 1.69) and 0.88 (CI-95%: -0.09 - 1.85), 
i.e. effects considered as intermediate in the terms 
recommended by Cohen (1988). This should draw attention to 
the fact that patients placed on waiting lists do not necessarily 
remain inactive, some may continue their investigations and use 
(self)treatment formulas that may lead to results that are 
sometimes similar to the most modest of those observed after 
formal treatment. 
6.5. Lifelong Severe PE 
Variations in outcomes do not appear to depend on the 
severity of PE as assessed on the basis of IELT criteria (≤ 1 min) 
recommended by the American Psychiatric Association [4] or 
the International Society for Sexual Medicine [7]. Similar gains 
in magnitude are observed in samples composed exclusively of 
subjects reporting baseline IELTs of less than two minutes and in 
those also reporting less severe forms of PE. Contrary to what 
has already been thought [8,9], behavioural methods would 
therefore also be effective in severe primary PE. As suggested 
by Kempeneers & Desseilles [63], the criterion of penetration 
times of less than one to two minutes to direct therapeutic 
preferences towards the pharmacological option would 
probably be poorly adjusted. This does not detract from the 
observation that the relative severity of PE may sometimes be 
a factor in a lower response to treatment, both behavioural 
[15,64] and pharmacological Waldinger [8], but the one-
minute cut-off of IELT does not seem relevant as a priori 
indicators of therapeutic modalities. 
6.6. Follow-up Periods 
The therapeutic effects do not seem to vary much according to 
the time elapsed since the end of treatment. Whether the 
measures are taken directly at the end of the follow-up or at 
three, six or twelve months of follow-up, they seem relatively 
constant. These observations somewhat contradict the concerns 
expressed by De Amicis et al. [33] and Hawton et al. [48] 
about the stability of therapeutic gains, these gains are 
probably not eroding as systematically as they feared or, in 
any case, they are not eroding very quickly. 
6.7. Amplitude of the Effects, Methodological Artefacts and 
Margins for Progress 
Comparing protocols in terms of their results is an operation 
that requires caution. The small effect size observed in the 
Mohammadi et al. trial [34] would, for example, suggest that 
the hypothesis of a less effective treatment than most others 
should be first interpreted. However, it cannot be ignored that 
the sample size of this study is particularly small (12 subjects), 
which places the estimate in very wide confidence intervals and 
therefore prohibits any hasty conclusion. 
It is also interesting to note that the penetration times reported 
in pertest by Mohammadi et al. [34] subjects appear, at an 
average of 2.33 minutes (± 0.88), to be higher than all those 
observed in the other studies. At 3.16 minutes post-test, 
however, they are in the low average of what is found in other 
studies. The small size of the effect could therefore also be 
explained by the smaller margin of progression left for 
Mohammadi and his colleagues to achieve a result equivalent 
to those obtained in other protocols.  
At the other end of the spectrum, where efficacy measures 
appear to be highest, note the standard sex therapy of Trudel 
& Proulx [40], the classic and functional-sexological 
behavioural treatments and group sex therapy of Pavone et 
al. [35]. These treatments give quite spectacular results since 
the IELTs are multiplied by six to eleven to reach six to eleven 
minutes. By way of comparison, in studies by Tang et al. [32], 
Jern [43], Mohammadi et al. [34], Cui et al. [44] and 
Rodriguez et al. [45], IELTs are multiplied by two to three to 
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reach only two to four minutes. Such differences may be due in 
particular to statistical artefacts: the standard deviations 
reported in the De Carufel and Trudel study are indeed very 
large and, when dealing with small numbers, a few particularly 
high IELT values may be sufficient to significantly increase 
geometric means; indeed, when examined in terms of effect 
sizes, the gains reported by De Carufel and Trudel do not 
appear to be so "spectacular". The same reasoning applies to 
the results reported by Golden et al. [37]. 
Note that when asked to report what they think are their 
penetration times after treatment (subjective IELT), the 
participants in De Carufel and Trudel's study report shorter 
latency than when they time them. This could indicate that there 
is, in fact, a difference between what some men are able to do 
during a particular coitus (in this case the one they are timing) 
and what most people, perhaps including themselves, aspire to 
most of the time. In this sense, studies showing the highest post-
treatment IELT values may reflect the occasional expression of 
a control capacity that exceeds usual aspirations and 
achievements. It is also perhaps this difference between a point 
capacity and a usual optimum that would be reflected in the 
difference observed in Pavone et al. [35] between spectacular 
effect sizes obtained in terms of IELT (d = 12.39) and more 
modest on the PEDT scale (d = 0.99). 
These latter considerations bring us back to the question of 
margins for progress. These would depend on the initial 
situation, as perhaps illustrated by the study by Mohammadi et 
al. [34], and would be limited by a kind of therapeutic ceiling 
effect corresponding to optimal sexual functioning. However, 
IELT chronometric measurements are probably not the best way 
to determine this optimum. Composite measures would 
undoubtedly be more appropriate, but practices are more 
heterogeneous in this respect, and standardization must be 
called for. 
The hypothesis of margins of progression determined, on the 
one hand, by the initial situation of the subjects and, on the 
other hand, by a possible ceiling effect may be further 
illustrated by comparing the trials of Pavone et al. [35] and 
Cormio et al. [41]. On the PEDT scale, the effect sizes are much 
smaller in the first case (d = 0.92) than in the second (d = 
7.03). This is mainly due to the fact that, in pre-test, the 
beneficiaries of the combined treatment implemented by 
Pavone's team reported a less dramatic situation (13.44 points) 
than did the beneficiaries of the combined treatment proposed 
by the Cormio team (19.56 points), while post-test 
measurements are much closer (5.11 and 7.92 points). 
6.8. Specific Techniques 
Variations in results from one trial to another must be assessed 
with all the caution required by sometimes small sample sizes 
and the possible play of unequal margins for progress. 
However, it is doubtful that methodological artefacts alone can 
explain all of them, and differences in treatment modalities 
certainly play a role.  
Pause-breaking techniques have several variants: they may or 
may not include squeeze and may or may not be supported by 
the assistance of a vibrating device. They can also be 
presented as a major active ingredient in the treatment, 
highlighting a desensitization process, or as an accessory or 
even negligible ingredient among other body techniques aimed 
at regulating excitation (e. g. slowing copulatory movements, 
regulating breathing, and distributing sensory-motor tensions 
over the whole body). These elements of technical variation do 
not seem to be decisive in examining the effectiveness of 
behavioural methods. It does seem quite indifferent to put the 
emphasis more on a regulatory objective, like in trials including 
exercises that target multiple components of sexual excitement, 
or on a desensitization objective, like in trials more strictly 
focused on stop-start exercises. In terms of results both modes 
of operation seem to be valid. Furthermore, adding penile 
compressions during the stopping phases does not appear to 
enhance the efficiency of the stop-start method, and the 
complementary use of a vibratory device does not seem to 
clearly produce better results either. All things considered, 
these adjunctions remain probably dispensable.  
On the other hand, there is a relative ineffectiveness of break 
techniques when they are subordinated to a sphincter control 
training objective, as is the case in the sex therapy arm alone 
of the Rodriguez et al. trial [45]. The same is true in 
Mantovani's trial where the techniques of pauses appear 
diluted in a program of strengthening the pubo-coccygeal 
musculature assisted by bio-feedback. The percentages of 
improvement at six months do not exceed 25%. This finding of 
limited effectiveness is in line with De Carufel's [54] criticism of 
pelvic floor rehabilitation methods considered by him as 
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ineffective in PE problems, or as indirectly effective, as he 
believes would be the case in a study published in 1996 by La 
Pera and Nicastro [65]. De Carufel believes that it is possible 
that the benefit of pelvic-focused physiotherapy exercises, 
when available, is due to mechanisms implicitly mobilized by 
them: relaxation of the perineum, for example, or increased 
attention and habituation to feelings of excitement [54]. In a 
2014 study, Pastore and colleagues report similar perplexity 
when discussing the improvements that they have observed in 
PE patients treated with a pelvic muscle rehabilitation program. 
The instructions accompanying such exercises, as they state in 
their article, as well as their nature and quantity vary greatly 
between protocols, so their mode of action remains unclear 
[66]. It is interesting to note that Rodriguez, Marzo & Piqueras' 
[45] introduction, in the second arm of their trial, of a vibrating 
device to supplement stop-start exercises is sufficient to 
produce results closer to those usually associated with 
behavioural methods. Rodriguez and his colleagues explain this 
gain by the effect of the vibrator itself but, considering the lack 
of clear variations in results between studies using a vibrating 
device and those not using it, one may wonder whether the 
benefit of the vibrator could not be explained essentially by 
the fact that its use would have allowed patients to refocus on 
a more realistic desensitization objective.  
In short, technical variants may not be as important as clarity of 
purpose for the user. Reconditioning your ejaculatory reflex or 
strengthening your pelvic floor probably doesn't make much 
sense. On the other hand, getting used to feelings of 
excitement (i.e. desensitization) and developing skills that make 
it possible not to automatically give in to a spontaneous 
propensity to outbid (i.e. regulation) seem to be coherent aims 
that guarantee the proper use of the exercises proposed for 
these purposes, the stop-start or others. This leads to 
questioning the quality and intensity of psychotherapeutic 
supervision. The following considerations highlight the very 
likely importance of this. 
6.9. Psychotherapeutic Support 
While the choice of technical tools (stop start with or without 
vibrating device, with or without compression or regulation 
techniques) appears relatively secondary, it is crucial that 
subjects have a realistic perception of their purpose; of what 
they can or cannot expect from it and how they can adapt 
them to their individual situation. This may help to explain why 
the protocols of Trudel & Proulx [40], and Pavone et al. [35] 
seem to stand out from the crowd. It is indeed possible to 
imagine that the essential part of psycho education and 
adjustment of therapeutic strategies is more easily ensured in 
dense accompaniments where time is taken to circulate 
information, such as the protocols. Pavone et al. [35], than when 
patients are simply given written instructions [46,47], whether 
the focus is on launching a masturbatory exercise program 
[43,44] or whether expectations of effectiveness focused on 
sphincter control are instilled [42,45]. It should be noted that 
the treatments proposed by De Carufel & Trudel and Pavone 
et al. [35] lasted 12 and 14 weeks respectively, compared to 
6 weeks for the treatments proposed by Jern [43] and Cui et 
al. [44] and 7 weeks for the treatment proposed by Rodriguez, 
Marzo & Piqueras [45], i.e. half as long. This may also 
contribute to the difference in results. The duration of 
treatments is certainly not in itself a guarantee of their quality, 
but it cannot be denied that time is a factor conducive to the 
construction of a therapeutic alliance and the development of 
exchanges aimed at explaining therapeutic principles, 
describing exercises, evaluating them and making subsequent 
adjustments. It is remarkable, in any case, that Pavone and his 
colleagues specified that they attach importance to discussing 
the "meaning of sexual dysfunction [in order to help their 
patients to develop internal and relational competence useful 
to] achieve a most satisfying quality of life" [35]. This is not 
simply a matter of applying behavioural "recipes" but of 
integrating their purpose, understanding their modes of action 
and addressing related elements. 
6.10. Self-Treatment 
Careful support certainly facilitates the efficient 
implementation of treatments. This is further evidenced by the 
loss of income associated with some self-treatment formulas. 
The intermediate effect size observed in Kempeneers et al. 
[46,47] are likely an expression of this: the therapeutic 
intervention was almost exclusively limited here to providing 
participants with a self-treatment guide. The formula was 
somewhat impersonal, unsupportive and, at the end of six 
months after the distribution of the material, a significant 
proportion of dissatisfied subjects explained that, for various 
reasons (e.g., lack of sufficient privacy, lack of availability or 
Urology : Research And Therapeutics Journal 
 011 
Sex Therapy for Premature Ejaculation: An Overview. Urology : Research And Therapeutics Journal. 2019; 2(2):128. 
collaboration of a partner, or lack of understanding of certain 
elements), they simply did not have the opportunity to fully 
apply or appreciate the therapeutic guidelines recommended 
in the document [46]. A minimum therapeutic contact (45 to 90 
minutes) was then established to support participants who 
wished to do so and to possibly help them adjust the written 
instructions to their individual situation. This procedure 
produced a slight improvement in the results but was not 
sufficient to raise the statistical significance threshold [47]. This 
relative inadequacy of results attributable to self-treatment 
formulas had already been pointed out by Zeiss [38] and 
Trudel & Proulx [40] who, compared to a traditional face-to-
face formula, observed, in the case of self-treatment, no to 
moderate improvements and a high proportion of dropouts. 
Therapeutic compliance would probably be the weak point of 
bibliotherapy. 
Despite its suboptimal nature, self-care sometimes appears to 
be the only possible sex therapy option, due to difficulties in 
accessing qualified providers or reluctance to discuss an 
intimate issue with a third party [67,68]. Under these 
conditions, the formula remains a valuable alternative to drug 
therapy as a first-line intervention. 
6.11. Factors Related to the Partner  
Partner-related factors certainly play a role in predicting 
outcomes. Blanken et al. [64] observed that the results obtained 
by Van Lankveld et al. [51] were, on the one hand, 
proportional to the quality of the participants' marital 
relationship and, on the other hand, inversely proportional to 
the number of sexual difficulties reported in the partner. 
Pavone et al. [35] reported that couple difficulties were a 
significant cause of stopping their treatment. As stated above, 
Kempeneers et al. [46] noted that a number of participants 
who reported that they had not benefited from the proposed 
treatment incriminated a partner's unavailability or lack of 
collaboration or hostility as an explanation for their treatment 
failure.  
The way in which relational factors are taken into account 
varies according to the protocols and with it, probably, the 
effect sizes. At one pole, there are trials that specifically target 
a couple, which excludes from the outset men without a steady 
partner and sets a minimum collaboration between spouses as 
a condition for access to the protocol. Because of its conjugal 
dimension, the processing is also designed precisely to optimize 
exchanges between partners. The protocols of Cui et al. [44], 
Trudel & Proulx [40] are good examples of these treatments, 
which take conjugal collaboration both as an object and as a 
recruitment condition, and are associated with rather large 
effect sizes. In the protocol by Pavone et al. [35], also 
associated with large effect sizes, cases of discontinuation of 
treatment due to relational difficulties were therefore also 
excluded from the analyses. At the other end of the spectrum 
are the trials by Kempeneers et al. [46,47] that recruited their 
participants regardless of their relationship situation and left it 
to their sole discretion whether or not to communicate with their 
partner about the therapeutic instructions received in writing. 
The effect sizes here are intermediate. It seems quite plausible 
that the differences in results are due in particular to 
differences in protocol considerations for partner-related 
factors. 
Collaboration between partners is certainly a factor in 
improving the problem but, in practice, it is not always possible. 
6.12. Sex therapy and drug therapy 
Studies comparing behavioural monotherapy with drug 
monotherapy are inconclusive. They sometimes point to a 
superiority of the behavioural approach [35,44], sometimes to 
a superiority of the pharmacological approach [29,30], 
sometimes to equivalence [42,49]. Much depends on the nature 
and dosage of the products used as well as the type and 
density of behavioural treatments.  
Combination treatments almost all appear to be superior in 
effect to behavioural or pharmacological monotherapy. A 
molecule designed to delay ejaculation can promote the 
learning necessary to control excitement just as learning can 
help control ejaculation which, although delayed by the effect 
of a drug, would remain too fast. It is also clear that sex 
therapy often addresses a range of relational and behavioural 
parameters that, although unrelated to the duration of 
penetration per se, contribute to increased dissatisfaction 
among men and couples facing the problem, such as a possible 
tendency to focus on coital relationships to the detriment of 
other forms of erotic stimulation [69]. The two approaches do 
not help people in the same way, they are obviously 
complementary. The addition of one method addresses the 
relative deficiencies of the other, it is logical, and this is what 
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the tests reviewed tend to confirm. Some of the variations in 
results are, of course, due to the molecules used and their 
dosage, but this goes beyond the scope of this article. It is 
interesting to note, however, that in the trial by Pavone et al. 
[35], dapoxetine treatment does not add anything to the 
effects of sex therapy, which are already among the most 
important in the series under consideration. This refers to the 
hypothesis of a ceiling effect that would limit the margins for 
progress and invite us to remember that voluntary control can 
be obtained from behavioural treatment provided that it is 
carried out under optimal conditions. Studies are still needed to 
clarify these. 
CONCLUSIONS  
Behavioural treatments of PE produce intermediate to large 
effects. They generally use stop-start break techniques. It does 
not seem essential to combine these techniques with penile 
compression (i.e. squeeze) or the use of a vibrating device. We 
usually expect a habituation desensitization of the beneficiaries 
to feelings of excitement; we also expect a slowing effect of 
the psycho-physiological and motor dynamics that 
characterizes excitement. To this end, it is also possible to use 
other techniques (postural, respiratory, motor) qualified as 
"regulating" or "functional-sexological", which can be combined 
or even replace breaks. Break techniques and regulatory 
techniques seem to be equivalent, but they may not be equally 
effective with the same people, so it would probably be best 
to combine them. Exercises specifically designed to strengthen 
the pelvic floor, on the other hand, do not in themselves seem to 
be a promising therapeutic vector, their effects would 
probably be indirect.  
Beyond the techniques specifically applicable to PE problems, 
it is necessary to ensure their proper use. This requires support 
for the patient, and ideally for his partner, to address 
cognitive, behavioural, relational or other issues related to the 
complaint. The most effective protocols are probably also those 
that focus on this aspect of things. 
There is a tendency to favour pharmacological treatments 
when dealing with severe forms of PE [9] and to offer sex 
therapy only if the drug approach fails or is insufficient. Such 
an algorithm does not appear to be supported by the data 
reviewed. Perhaps it would even be appropriate, because of 
possible adverse effects related to the use of certain 
substances, to reverse the recommendation and, as previously 
suggested by Assalian [20], to make sex therapy the preferred 
indication with, if necessary, alternative or supportive 
medication. 
In practice, access to sex therapy may be difficult, for example 
because of its cost or insufficient supply. In this case, it is 
possible to offer tried and tested forms of self-treatment as a 
first line of action, while keeping in mind that these forms are 
not necessarily adapted to the particular situations of all 
people.  
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